Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000950137-04-004200
Filing Date
2004-05-17
Accepted
2004-05-17 16:56:40
Documents
6
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT c85622e10qsb.htm 10QSB 191689
2 FIRST AMENDMENT TO LEASE c85622exv10w1.htm EX-10.1 17557
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c85622exv31w1.htm EX-31.1 6115
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER c85622exv31w2.htm EX-31.2 6123
5 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c85622exv32w1.htm EX-32.1 2568
6 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER c85622exv32w2.htm EX-32.2 2612
  Complete submission text file 0000950137-04-004200.txt   228977
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 001-31812 | Film No.: 04813249
SIC: 2836 Biological Products, (No Diagnostic Substances)